One of the unknown factors in the use of high-intensity focused ultrasound (HIFU) for the first-line treatment of prostate cancer is the potential for high-quality, biochemical recurrence-free survival over time. Post-treatment histopathology may offer some insight into the likelihood of good outcomes.
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, histopathology, pathology | 9 Comments »

Search for new and
ongoing trials on the
CTAG PCa web site
